- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting of NMDA receptors in new treatments for schizophrenia
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 18, Issue 9, Pages 1049-1063
Publisher
Informa Healthcare
Online
2014-06-26
DOI
10.1517/14728222.2014.934225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative stress and schizophrenia
- (2014) Francesco E. Emiliani et al. CURRENT OPINION IN PSYCHIATRY
- A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia – Results from the CandleLyte study
- (2014) D. Bugarski-Kirola et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Prevention: Before the break
- (2014) Michele Solis NATURE
- Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies
- (2014) M.J. Stuart et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Clinically meaningful biomarkers for psychosis: A systematic and quantitative review
- (2014) Diana Prata et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Abnormalities of the glutamine–glutamate–GABA cycle in the schizophrenia brain
- (2014) Kenji Hashimoto SCHIZOPHRENIA RESEARCH
- N-acetylcysteine prevents increased amphetamine sensitivity in social isolation-reared mice
- (2014) Ana P. Herrmann et al. SCHIZOPHRENIA RESEARCH
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Bitopertin
- (2014) Donald C. Goff JAMA Psychiatry
- Increased Glutamine in Patients Undergoing Long-term Treatment for Schizophrenia
- (2014) Juan R. Bustillo et al. JAMA Psychiatry
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
- (2013) Mehdi Farokhnia et al. CLINICAL NEUROPHARMACOLOGY
- D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy
- (2013) Silvia Sacchi et al. CURRENT PHARMACEUTICAL DESIGN
- Biomarkers in Schizophrenia: A Brief Conceptual Consideration
- (2013) Cynthia S. Weickert et al. DISEASE MARKERS
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
- (2013) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine
- (2013) K. Sunitha et al. FREE RADICAL RESEARCH
- Up-Regulation of Neurotrophic Factors by Cinnamon and its Metabolite Sodium Benzoate: Therapeutic Implications for Neurodegenerative Disorders
- (2013) Arundhati Jana et al. Journal of Neuroimmune Pharmacology
- Disruption of Shmt1 Impairs Hippocampal Neurogenesis and Mnemonic Function in Mice
- (2013) Elena V. Abarinov et al. JOURNAL OF NUTRITION
- Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
- (2013) E M P Poels et al. MOLECULAR PSYCHIATRY
- Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals
- (2013) C-H Lin et al. MOLECULAR PSYCHIATRY
- Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: Reversal with galantamine
- (2013) K.S. Alexander et al. NEUROSCIENCE
- Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine
- (2013) Hiroko Hagiwara et al. PLoS One
- Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
- (2013) I. E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
- (2013) Virginia L. Stauffer et al. SCHIZOPHRENIA RESEARCH
- The promise of N-acetylcysteine in neuropsychiatry
- (2013) Michael Berk et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models
- (2012) Anita Kulak et al. ANTIOXIDANTS & REDOX SIGNALING
- The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
- (2012) Jan Lewerenz et al. ANTIOXIDANTS & REDOX SIGNALING
- N-Acetylcysteine ethyl ester (NACET): A novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential
- (2012) Daniela Giustarini et al. BIOCHEMICAL PHARMACOLOGY
- Is D-Cycloserine a Prodrug for D-Serine in the Brain?
- (2012) Mao Horio et al. BIOLOGICAL PSYCHIATRY
- Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine
- (2012) Jan-Harry Cabungcal et al. BIOLOGICAL PSYCHIATRY
- Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?
- (2012) Kenji Hashimoto CNS & Neurological Disorders-Drug Targets
- Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia
- (2012) Thomas L. Schwartz et al. CURRENT PHARMACEUTICAL DESIGN
- Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases
- (2012) Tomihisa Niitsu et al. CURRENT PHARMACEUTICAL DESIGN
- Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
- (2012) C S Weickert et al. MOLECULAR PSYCHIATRY
- Kynurenines in the mammalian brain: when physiology meets pathology
- (2012) Robert Schwarcz et al. NATURE REVIEWS NEUROSCIENCE
- Glycine Transporter Type 1 Occupancy by Bitopertin: a Positron Emission Tomography Study in Healthy Volunteers
- (2012) Meret Martin-Facklam et al. NEUROPSYCHOPHARMACOLOGY
- Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial
- (2012) Cristian Carmeli et al. PLoS One
- Role of Serine Racemase in Behavioral Sensitization in Mice after Repeated Administration of Methamphetamine
- (2012) Mao Horio et al. PLoS One
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individuals
- (2012) Elson Asevedo et al. REVIEWS IN THE NEUROSCIENCES
- Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
- (2012) D. C. Javitt et al. SCHIZOPHRENIA BULLETIN
- NMDA Receptor and Schizophrenia: A Brief History
- (2012) J. T. Coyle SCHIZOPHRENIA BULLETIN
- Plasma levels of D-serine in Brazilian individuals with schizophrenia
- (2012) Marilia A. Calcia et al. SCHIZOPHRENIA RESEARCH
- Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration
- (2012) Yumi Shirai et al. Clinical Psychopharmacology and Neuroscience
- Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
- (2011) Ikwunga Wonodi ARCHIVES OF GENERAL PSYCHIATRY
- Glutamatergic Modulation of Auditory Information Processing in the Human Brain
- (2011) Handan Gunduz-Bruce et al. BIOLOGICAL PSYCHIATRY
- N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development
- (2011) Joao Miguel das Neves Duarte et al. BIOLOGICAL PSYCHIATRY
- α7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia
- (2011) Masatomo Ishikawa et al. CURRENT PHARMACEUTICAL DESIGN
- Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
- (2011) Dana V. Ferraris et al. CURRENT PHARMACEUTICAL DESIGN
- Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia
- (2011) Kenji Hashimoto et al. CURRENT PHARMACEUTICAL DESIGN
- Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects
- (2011) Norbert Muller et al. CURRENT PHARMACEUTICAL DESIGN
- Levels of d-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice
- (2011) Mao Horio et al. NEUROCHEMISTRY INTERNATIONAL
- Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia
- (2011) Daniela Alberati et al. NEUROPHARMACOLOGY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine
- (2011) Hongxian Chen et al. PSYCHOPHARMACOLOGY
- Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine
- (2011) Kathleen S. Alexander et al. PSYCHOPHARMACOLOGY
- Translating Glutamate: From Pathophysiology to Treatment
- (2011) D. C. Javitt et al. Science Translational Medicine
- Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
- (2010) Daisuke Matsuzawa et al. ANTIOXIDANTS & REDOX SIGNALING
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia
- (2010) Emmanuel Pinard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia
- (2010) Motoko Maekawa et al. JOURNAL OF NEUROCHEMISTRY
- Redox Dysregulation Affects the Ventral But Not Dorsal Hippocampus: Impairment of Parvalbumin Neurons, Gamma Oscillations, and Related Behaviors
- (2010) P. Steullet et al. JOURNAL OF NEUROSCIENCE
- Glutamate Receptor Ion Channels: Structure, Regulation, and Function
- (2010) S. F. Traynelis et al. PHARMACOLOGICAL REVIEWS
- Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
- (2010) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
- (2010) K. V. Sathyasaikumar et al. SCHIZOPHRENIA BULLETIN
- Developmental Vitamin D Deficiency and Risk of Schizophrenia: A 10-Year Update
- (2010) J. J. McGrath et al. SCHIZOPHRENIA BULLETIN
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
- (2009) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia
- (2009) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- NMDA- and -Amyloid1-42-Induced Neurotoxicity Is Attenuated in Serine Racemase Knock-Out Mice
- (2009) R. Inoue et al. JOURNAL OF NEUROSCIENCE
- Comments on ‘The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia’
- (2009) Kenji Hashimoto JOURNAL OF PSYCHOPHARMACOLOGY
- The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
- (2009) L Verrall et al. MOLECULAR PSYCHIATRY
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
- (2009) Arun Sreekumar et al. NATURE
- Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: A preliminary study
- (2009) Yukihiko Shirayama et al. NEUROIMAGE
- Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients
- (2009) Monia Raffa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Regarding “N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial”
- (2008) Kenji Hashimoto BIOLOGICAL PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Synthesis and Biological Evaluation ofd-Amino Acid Oxidase Inhibitors
- (2008) Dana Ferraris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Medial temporal lobe glutathione concentration in first episode psychosis: A 1H-MRS investigation
- (2008) Stephen J. Wood et al. NEUROBIOLOGY OF DISEASE
- Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study
- (2008) Daisuke Matsuzawa et al. PLoS One
- d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats
- (2007) Jun-ichi Karasawa et al. BEHAVIOURAL BRAIN RESEARCH
- Sarcosine (N-Methylglycine) Treatment for Acute Schizophrenia: A Randomized, Double-Blind Study
- (2007) Hsien-Yuan Lane et al. BIOLOGICAL PSYCHIATRY
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine
- (2007) Kenji Hashimoto et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Neurophysiological biomarkers for drug development in schizophrenia
- (2007) Daniel C. Javitt et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now